PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för rolipram. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

46 hits

Bibliografisk träff 2009-06-25

Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.

Tokuhara Y, Wakitani S, Imai Y, Nomura C, Hoshino M, Yano K, Taguchi S, Kim M, Kadoya Y, Takaoka K.

J Bone Miner Metab · comparative study; journal article · DOI 10.1007/s00774-009-0103-5

Bibliografisk träff 2009-01-01

Systemic administration of rolipram increases medullary and spinal cAMP and activates a latent respiratory motor pathway after high cervical spinal cord injury.

Kajana S, Goshgarian HG.

J Spinal Cord Med · research-article; journal article; research support, n.i.h., extramural · DOI 10.1080/10790268.2009.11760769

Bibliografisk träff 2008-09-01

Rolipram, a phosphodiesterase type IV inhibitor, exacerbates periventricular white matter lesions in rat pups.

Chang YC, Huang CC, Hung PL, Huang HM.

Pediatr Res · journal article · DOI 10.1203/pdr.0b013e31817cfc87

Bibliografisk träff 2008-06-13

Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats.

Görür S, Celik S, Hakverdi S, Aslantaş O, Erdoğan S, Aydin M, Ocak S, Namik Kiper A.

Urology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.urology.2008.04.013

Bibliografisk träff 2008-03-17

Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.

Xin W, Tran TM, Richter W, Clark RB, Rich TC.

J Gen Physiol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1085/jgp.200709881

Bibliografisk träff 2008-03-07

Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease.

DeMarch Z, Giampà C, Patassini S, Bernardi G, Fusco FR.

Neurobiol Dis · comparative study; journal article · DOI 10.1016/j.nbd.2008.02.010

Bibliografisk träff 2008-03-03

Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.

Campos-Toimil M, Keravis T, Orallo F, Takeda K, Lugnier C.

Br J Pharmacol · other; research support, non-u.s. gov't; journal article · DOI 10.1038/bjp.2008.56

Bibliografisk träff 2007-05-01

A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells.

Narita M, Murata T, Shimizu K, Nakagawa T, Sugiyama T, Inui M, Hiramoto K, Tagawa T.

Oncol Rep · journal article · DOI 10.3892/or.17.5.1133

Bibliografisk träff 2007-04-01

Rolipram, a phosphodiesterase 4 inhibitor, suppresses PGE2-induced osteoclast formation by lowering osteoclast progenitor cell viability.

Park H, Yim M.

Arch Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/bf02980224

Bibliografisk träff 2006-11-01

Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.

Kanes SJ, Tokarczyk J, Siegel SJ, Bilker W, Abel T, Kelly MP.

Neuroscience · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.neuroscience.2006.09.026

Bibliografisk träff 2006-10-25

Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.

Oger S, Behr-Roussel D, Gorny D, Denys P, Lebret T, Alexandre L, Giuliano F.

Eur Urol · journal article · DOI 10.1016/j.eururo.2006.10.023

Bibliografisk träff 2006-09-12

Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.

Sohara E, Rai T, Yang SS, Uchida K, Nitta K, Horita S, Ohno M, Harada A, Sasaki S, Uchida S.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; journal article · DOI 10.1073/pnas.0602331103

Bibliografisk träff 2006-09-08

Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons.

Shrestha BR, Vitolo OV, Joshi P, Lordkipanidze T, Shelanski M, Dunaevsky A.

Mol Cell Neurosci · comparative study; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.mcn.2006.07.011

Bibliografisk träff 2006-02-02

Anti-inflammatory and relaxatory effects of prostaglandin E2 in myometrial smooth muscle.

Slater DM, Astle S, Woodcock N, Chivers JE, de Wit NC, Thornton S, Vatish M, Newton R.

Mol Hum Reprod · research support, non-u.s. gov't; journal article · DOI 10.1093/molehr/gal005

Bibliografisk träff 2006-01-25

Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.

Harada D, Tsukumo Y, Takashima Y, Manabe H.

Eur J Pharmacol · comparative study; journal article · DOI 10.1016/j.ejphar.2005.12.005

Bibliografisk träff 2005-11-01

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.

Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J.

Neurobiol Dis · research support, non-u.s. gov't; journal article · DOI 10.1016/j.nbd.2005.03.002

Bibliografisk träff 2005-10-27

Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.

Videla S, Vilaseca J, Medina C, Mourelle M, Guarner F, Salas A, Malagelada JR.

J Pharmacol Exp Ther · research support, non-u.s. gov't; journal article · DOI 10.1124/jpet.105.090837

Bibliografisk träff 2005-10-01

Effect of rolipram, a phosphodiesterase IV inhibitor, on allergic footpad swelling using various adjuvants in mice.

Yamaki K, Alam AH, Hossain MA, Taneda S, Yanagisawa R, Takano H, Yoshino S.

Scand J Immunol · journal article · DOI 10.1111/j.1365-3083.2005.01662.x

Bibliografisk träff 2005-09-01

Elastolytic activity and alveolar epithelial type-1 cell damage after chronic LPS inhalation: effects of dexamethasone and rolipram.

Johnson FJ, Reynolds LJ, Toward TJ.

Toxicol Appl Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.taap.2005.01.006

Bibliografisk träff 2005-09-01

Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration.

D'Sa C, Eisch AJ, Bolger GB, Duman RS.

Eur J Neurosci · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1111/j.1460-9568.2005.04321.x

Bibliografisk träff 2005-08-01

Effects of rolipram on induction of action potential bursts in central snail neurons.

Lin CH, Lin PJ, Chen YH, Lin PL, Chen IM, Lu KL, Chang YC, Tsai MC.

Exp Neurol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.expneurol.2005.02.016

Bibliografisk träff 2005-08-01

Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation.

Sato Y, Hiramatsu Y, Homma S, Sato M, Sato S, Endo S, Sohara Y.

J Thorac Cardiovasc Surg · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jtcvs.2004.12.028

Bibliografisk träff 2005-06-01

Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates aspirin-induced gastric mucosal injury in rats.

Odashima M, Otaka M, Jin M, Komatsu K, Konishi N, Wada I, Horikawa Y, Matsuhashi T, Ohba R, Oyake J, Hatakeyama N, Watanabe S.

Dig Dis Sci · journal article · DOI 10.1007/s10620-005-2711-9

Bibliografisk träff 2005-04-01

Rolipram attenuates MK-801-induced deficits in latent inhibition.

Davis JA, Gould TJ.

Behav Neurosci · research support, non-u.s. gov't; journal article · DOI 10.1037/0735-7044.119.2.595

Bibliografisk träff 2005-03-24

Essential role of a Ca2+-selective, store-operated current (ISOC) in endothelial cell permeability: determinants of the vascular leak site.

Wu S, Cioffi EA, Alvarez D, Sayner SL, Chen H, Cioffi DL, King J, Creighton JR, Townsley M, Goodman SR, Stevens T.

Circ Res · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1161/01.res.0000163632.67282.1f

Bibliografisk träff 2005-02-01

Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts.

Cho ES, Yu JH, Kim MS, Yim M.

Yonsei Med J · research support, non-u.s. gov't; research-article; journal article · DOI 10.3349/ymj.2005.46.1.149

Bibliografisk träff 2005-01-01

Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.

Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.

Cell Mol Biol Lett · journal article

Bibliografisk träff 2005-01-01

Phosphodiesterase inhibitors for cognitive enhancement.

Rose GM, Hopper A, De Vivo M, Tehim A.

Curr Pharm Des · review; journal article · DOI 10.2174/138161205774370799

Bibliografisk träff 2004-12-01

Rolipram, a phosphodiesterase 4 inhibitor, stimulates osteoclast formation by inducing TRANCE expression in mouse calvarial cells.

Cho ES, Yu JH, Kim MS, Yim M.

Arch Pharm Res · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/bf02975891

Bibliografisk träff 2004-08-01

Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus.

Zhang HT, Zhao Y, Huang Y, Dorairaj NR, Chandler LJ, O'Donnell JM.

Neuropsychopharmacology · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1038/sj.npp.1300440